Literature DB >> 31222503

Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse.

Jay C Jha1, Aozhi Dai1, Chet E Holterman2, Mark E Cooper1, Rhian M Touyz3, Chris R Kennedy2, Karin A M Jandeleit-Dahm4,5.   

Abstract

AIMS/HYPOTHESIS: Excessive production of reactive oxygen species (ROS) plays a detrimental role in the progression of diabetic kidney disease (DKD). Renal oxidative stress activates proinflammatory cytokines, chemokines and profibrotic factors in DKD. Increased expression of the prooxidant enzyme NADPH oxidase (NOX) 5 in kidneys of diabetic individuals has been hypothesised to correlate with renal injury and progression of DKD. Since the gene encoding NOX5 is not expressed in the mouse genome, we examined the effect of inducible human NOX5 expression in renal cells, selectively in either endothelial cells or vascular smooth muscle cells (VSMCs)/mesangial cells in a model of insulin-deficient diabetes, the Akita mouse.
METHODS: Renal structural injury, including glomerulosclerosis, mesangial expansion and extracellular matrix protein accumulation, as well as renal inflammation, ROS formation and albuminuria, were examined in the NOX5 transgenic Akita mouse model of DKD.
RESULTS: Expression of NOX5 in either endothelial cells or VSMCs/mesangial cells in diabetic Akita mice was associated with increased renal inflammation (monocyte chemoattractant protein-1, NF-κB and toll-like receptor-4) and glomerulosclerosis, as well as upregulation of protein kinase C-α and increased expression of extracellular matrix genes (encoding collagen III, fibronectin and α-smooth muscle actin) and proteins (collagen IV), most likely mediated via enhanced renal ROS production. The effect of VSMC/mesangial cell-specific NOX5 expression resulted in more pronounced renal fibrosis in comparison with endothelial cell-specific NOX5 expression in diabetic mice. In addition, albuminuria was significantly increased in diabetic VEcad+NOX5+ mice (1192 ± 194 μg/24 h) when compared with diabetic VEcad+NOX5- mice (770 ± 98 μg/24 h). Furthermore, the regulatory components of NOX5 activation, including heat shock protein 90 and transient receptor potential cation channel subfamily C member 6, were upregulated only in the presence of both NOX5 and diabetes. CONCLUSIONS/
INTERPRETATION: The findings from this study highlight the importance of NOX5 in promoting diabetes-related renal injury and provide the rationale for the development of a selective NOX5 inhibitor for the prevention and/or treatment of DKD.

Entities:  

Keywords:  Akita mouse; Albuminuria; Diabetic kidney disease; Endothelial cells; Glomerulosclerosis; VSMCs/mesangial cells

Year:  2019        PMID: 31222503     DOI: 10.1007/s00125-019-4924-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  40 in total

1.  Nephropathy in diabetes.

Authors:  Mark E Molitch; Ralph A DeFronzo; Marion J Franz; William F Keane; Carl Erik Mogensen; Hans-Henrik Parving; Michael W Steffes
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

Review 2.  Nox5 and the regulation of cellular function.

Authors:  David J R Fulton
Journal:  Antioxid Redox Signal       Date:  2009-10       Impact factor: 8.401

Review 3.  Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway.

Authors:  Xinghua Cheng; Richard C M Siow; Giovanni E Mann
Journal:  Antioxid Redox Signal       Date:  2010-08-20       Impact factor: 8.401

4.  Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney.

Authors:  Yves Gorin; Karen Block; James Hernandez; Basant Bhandari; Brent Wagner; Jeffrey L Barnes; Hanna E Abboud
Journal:  J Biol Chem       Date:  2005-08-31       Impact factor: 5.157

Review 5.  Molecular mechanisms of diabetic renal hypertrophy.

Authors:  G Wolf; F N Ziyadeh
Journal:  Kidney Int       Date:  1999-08       Impact factor: 10.612

6.  The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.

Authors:  A M D Watson; J Li; C Schumacher; M de Gasparo; B Feng; M C Thomas; T J Allen; M E Cooper; K A M Jandeleit-Dahm
Journal:  Diabetologia       Date:  2009-10-28       Impact factor: 10.122

7.  Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.

Authors:  Jay C Jha; Stephen P Gray; David Barit; Jun Okabe; Assam El-Osta; Tamehachi Namikoshi; Vicki Thallas-Bonke; Kirstin Wingler; Cedric Szyndralewiez; Freddy Heitz; Rhian M Touyz; Mark E Cooper; Harald H H W Schmidt; Karin A Jandeleit-Dahm
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

8.  Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.

Authors:  Jay C Jha; Vicki Thallas-Bonke; Claudine Banal; Stephen P Gray; Bryna S M Chow; Georg Ramm; Susan E Quaggin; Mark E Cooper; Harald H H W Schmidt; Karin A Jandeleit-Dahm
Journal:  Diabetologia       Date:  2015-10-28       Impact factor: 10.122

9.  Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes.

Authors:  Xiaoqing He; Hong Kan; Lu Cai; Qiang Ma
Journal:  J Mol Cell Cardiol       Date:  2008-11-01       Impact factor: 5.000

10.  Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy.

Authors:  Vicki Thallas-Bonke; Jay C Jha; Stephen P Gray; David Barit; Hermann Haller; Harald H H W Schmidt; Melinda T Coughlan; Mark E Cooper; Josephine M Forbes; Karin A M Jandeleit-Dahm
Journal:  Physiol Rep       Date:  2014-11-03
View more
  12 in total

Review 1.  Nox1 downregulators: A new class of therapeutics.

Authors:  Matthias Barton; Matthias R Meyer; Eric R Prossnitz
Journal:  Steroids       Date:  2019-09-10       Impact factor: 2.668

Review 2.  Signaling pathways of chronic kidney diseases, implications for therapeutics.

Authors:  Qian Yuan; Ben Tang; Chun Zhang
Journal:  Signal Transduct Target Ther       Date:  2022-06-09

Review 3.  NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook.

Authors:  Alberto Nascè; Karim Gariani; François R Jornayvaz; Ildiko Szanto
Journal:  Antioxidants (Basel)       Date:  2022-06-09

Review 4.  The future of diabetic kidney disease management: what to expect from the experimental studies?

Authors:  Federica Barutta; Stefania Bellini; Beatrice Corbetta; Marilena Durazzo; Gabriella Gruden
Journal:  J Nephrol       Date:  2020-03-27       Impact factor: 3.902

Review 5.  Oxidative Stress and Inflammation in Renal and Cardiovascular Complications of Diabetes.

Authors:  Amelia Charlton; Jessica Garzarella; Karin A M Jandeleit-Dahm; Jay C Jha
Journal:  Biology (Basel)       Date:  2020-12-30

Review 6.  Molecular Mechanisms in Early Diabetic Kidney Disease: Glomerular Endothelial Cell Dysfunction.

Authors:  Emelie Lassén; Ilse S Daehn
Journal:  Int J Mol Sci       Date:  2020-12-11       Impact factor: 5.923

7.  Mechanisms of podocyte injury and implications for diabetic nephropathy.

Authors:  Federica Barutta; Stefania Bellini; Gabriella Gruden
Journal:  Clin Sci (Lond)       Date:  2022-04-14       Impact factor: 6.124

Review 8.  Oxidative Stress and Hypertension.

Authors:  Kathy K Griendling; Livia L Camargo; Francisco J Rios; Rhéure Alves-Lopes; Augusto C Montezano; Rhian M Touyz
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

9.  NOX5-induced uncoupling of endothelial NO synthase is a causal mechanism and theragnostic target of an age-related hypertension endotype.

Authors:  Mahmoud H Elbatreek; Sepideh Sadegh; Elisa Anastasi; Emre Guney; Cristian Nogales; Tim Kacprowski; Ahmed A Hassan; Andreas Teubner; Po-Hsun Huang; Chien-Yi Hsu; Paul M H Schiffers; Ger M Janssen; Pamela W M Kleikers; Anil Wipat; Jan Baumbach; Jo G R De Mey; Harald H H W Schmidt
Journal:  PLoS Biol       Date:  2020-11-10       Impact factor: 8.029

Review 10.  Skeletal muscle redox signaling in rheumatoid arthritis.

Authors:  Maarten M Steinz; Estela Santos-Alves; Johanna T Lanner
Journal:  Clin Sci (Lond)       Date:  2020-11-13       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.